AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2023
Sep 22, 2023
32134_dirs_2023-09-21_5637a739-bfe6-4218-85aa-731f14732282.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2023-09-19
Reporting Person: GREER R SCOTT (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-09-19 | Stock Option | $0.68 | A | 85000 | Acquired | 2031-09-18 | Common Stock (85000) | Direct |
Footnotes
F1: This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023.
More from NEKTAR THERAPEUTICS
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 8
Annual Report
2026
Apr 24
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20